← All stocks

Ginkgo Bioworks Holdings, Inc.

DNA Net selling

CIK 0001830214 #3124 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$37.71K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$37.71K

2 of 2 sales

Net

−$37.71K

−$37.71K against sales at will

By person

12 insiders · 2 transactions

8.9×

Jason Kelly holds 8.9 times base salary in stock. $2.24M of shares against $250.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Jason Kelly last reported holding, valued at $7.08, the price Class A Common Stock was last bought or sold at on the open market here, on 15 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

HENRY CHRISTIAN O

Director

—

$35.41K (1)

−$35.41K

19,310

0.0303%

$136.73K

−42.3%

Coen Steven P.

See remarks

—

$2.30K (1)

−$2.30K

51,851

0.0814%

$367.16K

+824.4%

Canton Barry

10% owner

—

774,990

1.22%

$5.49M

+25.3%

Shetty Reshma P.

See remarks

—

774,990

1.22%

$5.49M

+25.3%

Kelly Jason R

See remarks

—

316,483

0.4967%

$2.24M

+225.0%

SLOAN HARRY

Director

—

271,418

0.4260%

$1.92M

+1,218%

Sankar Shyam

Director

—

72,372

0.1136%

$512.47K

+17.6%

Dmytruk Mark E.

See remarks

—

46,226

0.0726%

$327.33K

+60.8%

Kosuri Sri

Director

—

24,067

0.0378%

$170.42K

—

Hannan Kathy Hopinkah

Director

—

15,003

0.0235%

$106.24K

+258.8%

POTTER MYRTLE S

Director

—

10,822

0.0170%

$76.63K

—

Fubini Ross

Director

—

10,822

0.0170%

$76.63K

—

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 2

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 2

Transactions with no price 0

Shares from compensation/vesting 743

History held since 20 Sep 2021